<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) persists for life in a person who has been infected </plain></SENT>
<SENT sid="1" pm="."><plain>Investigators are uncertain what this means to the host, particularly an immunocompromised one </plain></SENT>
<SENT sid="2" pm="."><plain>EBV is the most common cause of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, but the diagnosis must be based on clinical, hematologic, and serologic criteria because other agents are the cause in about 10% of cases </plain></SENT>
<SENT sid="3" pm="."><plain>EBV is the first virus to be associated with a <z:hpo ids='HP_0002664'>neoplasm</z:hpo>--Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>This childhood <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> is relatively common in central Africa, and EBV is a cofactor in its development, although direct evidence for a causal relationship has not been found </plain></SENT>
<SENT sid="5" pm="."><plain>In southern China, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> is an important health problem in adults in areas where the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> rate of EBV in childhood is high </plain></SENT>
<SENT sid="6" pm="."><plain>Rare cases of primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> that evolved into uncontrolled <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> have also been reported </plain></SENT>
<SENT sid="7" pm="."><plain>EBV's relationship to these diverse diseases, its varying effects on certain individuals and in certain geographic locations, and the testing of a vaccine against the virus are areas of ongoing study </plain></SENT>
</text></document>